{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:17:42Z","timestamp":1789690662058,"version":"4.0.1"},"reference-count":343,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013804","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202492"],"award-info":[{"award-number":["82202492"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82151224"],"award-info":[{"award-number":["82151224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["QNTD2023-01"],"award-info":[{"award-number":["QNTD2023-01"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.lfs.2024.123340","type":"journal-article","created":{"date-parts":[[2024,12,25]],"date-time":"2024-12-25T10:55:52Z","timestamp":1735124152000},"page":"123340","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["A comprehensive review of research advances in the study of lactoferrin to treat viral infections"],"prefix":"10.1016","volume":"361","author":[{"given":"Amna","family":"Shafqat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maochen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Zakirullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feitong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigang","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0005","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/molecules26010205","article-title":"Lactoferrin: a glycoprotein involved in immunomodulation, anticancer, and antimicrobial processes","volume":"26","author":"Rasc\u00f3n-Cruz","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2024.123340_bb0010","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/2071007a0","article-title":"Polymorphism in the red protein isolated from milk of individual cows","volume":"207","author":"Groves","year":"1965","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1139\/o01-153","article-title":"Lactoferrin and transferrin: functional variations on a common structural framework","volume":"80","author":"Baker","year":"2002","journal-title":"Biochem. Cell Biol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/B:BIOM.0000027694.40260.70","article-title":"Lactoferrin and iron: structural and dynamic aspects of binding and release","volume":"17","author":"Baker","year":"2004","journal-title":"Biometals"},{"issue":"S1","key":"10.1016\/j.lfs.2024.123340_bb0025","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0007114500002191","article-title":"Occurrence, structure, biochemical properties and technological characteristics of lactoferrin","volume":"84","author":"Steijns","year":"2000","journal-title":"Br. J. Nutr."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb0030","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.3390\/nu11102350","article-title":"Lactoferrin in human milk of prolonged lactation","volume":"11","author":"Czosnykowska-\u0141ukacka","year":"2019","journal-title":"Nutrients"},{"issue":"14","key":"10.1016\/j.lfs.2024.123340_bb0035","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/ars.2015.6458","article-title":"Lactoferrin, a pleiotropic protein in health and disease","volume":"24","author":"Mayeur","year":"2016","journal-title":"Antioxid. Redox Signal."},{"issue":"22","key":"10.1016\/j.lfs.2024.123340_bb0040","doi-asserted-by":"crossref","first-page":"6016","DOI":"10.1080\/10408398.2021.1895063","article-title":"Lactoferrin: an overview of its main functions, immunomodulatory and antimicrobial role, and clinical significance","volume":"62","author":"Sienkiewicz","year":"2022","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/aps.2013.200","article-title":"Immunomodulatory effects of lactoferrin","volume":"35","author":"Siqueiros-Cend\u00f3n","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2024.123340_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2022.1018336","article-title":"Lactoferrin: a glycoprotein that plays an active role in human health","volume":"9","author":"Cao","year":"2023","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0055","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3168\/jds.2012-5692","article-title":"Effect of iron saturation level of lactoferrin on osteogenic activity in vitro and in vivo","volume":"96","author":"Wang","year":"2013","journal-title":"J. Dairy Sci."},{"issue":"24","key":"10.1016\/j.lfs.2024.123340_bb0060","doi-asserted-by":"crossref","first-page":"5763","DOI":"10.3390\/molecules25245763","article-title":"Lactoferrin and its derived peptides: an alternative for combating virulence mechanisms developed by pathogens","volume":"25","author":"Zarzosa-Moreno","year":"2020","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.lfs.2024.123340_bb0065","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/jac\/dkq106","article-title":"Evaluation of synergistic activity of bovine lactoferricin with antibiotics in corneal infection","volume":"65","author":"Oo","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2024.123340_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0014-5793(96)00168-8","article-title":"Antibacterial activity of peptides homologous to a loop region in human lactoferrin","volume":"382","author":"Odell","year":"1996","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb0075","doi-asserted-by":"crossref","first-page":"6992","DOI":"10.3390\/molecules16086992","article-title":"Antiviral properties of lactoferrin\u2014a natural immunity molecule","volume":"16","author":"Berlutti","year":"2011","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1207\/S15327914NC382_8","article-title":"Orally administered lactoferrin exerts an antimetastatic effect and enhances production of IL-18 in the intestinal epithelium","volume":"38","author":"Kuhara","year":"2000","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.lfs.2024.123340_bb0085","first-page":"1","article-title":"Nutraceutical and health-promoting potential of Lactoferrin, an Iron-binding protein in human and animal: current knowledge","author":"Ashraf","year":"2023","journal-title":"Biol. Trace Elem. Res."},{"key":"10.1016\/j.lfs.2024.123340_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105564","article-title":"Lactoferrin as a regenerative agent: the old-new panacea?","volume":"167","author":"Antoshin","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb0095","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.jiac.2014.08.003","article-title":"Lactoferrin for prevention of common viral infections","volume":"20","author":"Wakabayashi","year":"2014","journal-title":"J. Infect. Chemother."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1139\/bcb-2020-0035","article-title":"Antiviral effects of bovine lactoferrin on human norovirus","volume":"99","author":"Oda","year":"2021","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123340_bb0105","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s004300050049","article-title":"Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29","volume":"186","author":"Superti","year":"1997","journal-title":"Med. Microbiol. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0110","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1651-2227.1997.tb08896.x","article-title":"Effect of 1 human milk prostaglandins and lactoferrin on respiratory syncytial virus and rotavirus","volume":"86","author":"Grover","year":"1997","journal-title":"Acta Paediatr."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0115","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/infdis\/172.2.380","article-title":"Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro","volume":"172","author":"Harmsen","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.lfs.2024.123340_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-10-199","article-title":"Effectiveness of human, camel, bovine and sheep lactoferrin on the hepatitis C virus cellular infectivity: comparison study","volume":"10","author":"El-Fakharany","year":"2013","journal-title":"Virol. J."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0125","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1128\/JVI.79.5.3009-3015.2005","article-title":"Lactoferrin prevents dendritic cell-mediated human immunodeficiency virus type 1 transmission by blocking the DC-SIGN\u2014gp120 interaction","volume":"79","author":"Groot","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2024.123340_bb0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.antiviral.2014.08.012","article-title":"The intracellular inhibition of HCV replication represents a novel mechanism of action by the innate immune Lactoferrin protein","volume":"111","author":"Picard-Jean","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2024.123340_bb0135","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004300050093","article-title":"Inhibition of poliovirus type 1 infection by iron-, manganese-and zinc-saturated lactoferrin","volume":"187","author":"Marchetti","year":"1999","journal-title":"Med. Microbiol. Immunol."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb0140","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1002\/eji.200324218","article-title":"Lactoferrin and surfactant protein A exhibit distinct binding specificity to F protein and differently modulate respiratory syncytial virus infection","volume":"33","author":"Sano","year":"2003","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0145","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3390\/toxins2010054","article-title":"Reciprocal interactions between lactoferrin and bacterial endotoxins and their role in the regulation of the immune response","volume":"2","author":"Latorre","year":"2010","journal-title":"Toxins"},{"issue":"17","key":"10.1016\/j.lfs.2024.123340_bb0150","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/138161209788453202","article-title":"Lactoferrin as a natural immune modulator","volume":"15","author":"Actor","year":"2009","journal-title":"Curr. Pharm. Des."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0155","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nri1001","article-title":"Interleukin-12 and the regulation of innate resistance and adaptive immunity","volume":"3","author":"Trinchieri","year":"2003","journal-title":"Nat. Rev. Immunol."},{"issue":"20","key":"10.1016\/j.lfs.2024.123340_bb0160","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.3390\/ijms222011264","article-title":"Diverse mechanisms of antimicrobial activities of lactoferrins, lactoferricins, and other lactoferrin-derived peptides","volume":"22","author":"Gruden","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123340_bb0165","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.3389\/fimmu.2020.01221","article-title":"The biology of lactoferrin, an iron-binding protein that can help defend against viruses and bacteria","volume":"11","author":"Kell","year":"2020","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123340_bb0170","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/0929867326666190503121546","article-title":"Lactoferrin in bone tissue regeneration","volume":"27","author":"Icriverzi","year":"2020","journal-title":"Curr. Med. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0175","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1139\/o11-054","article-title":"Roles of lactoferrin on skin wound healing","volume":"90","author":"Takayama","year":"2011","journal-title":"Biochem. Cell Biol."},{"issue":"17","key":"10.1016\/j.lfs.2024.123340_bb0180","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1080\/10408398.2015.1137859","article-title":"A systematic review of lactoferrin use in dermatology","volume":"57","author":"Hassoun","year":"2017","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.lfs.2024.123340_bb0185","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s10534-010-9335-z","article-title":"Lactoferrin efficacy versus ferrous sulfate in curing iron deficiency and iron deficiency anemia in pregnant women","volume":"23","author":"Paesano","year":"2010","journal-title":"Biometals"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1139\/o06-054","article-title":"Bovine lactoferrin: benefits and mechanism of action against infections","volume":"84","author":"Yamauchi","year":"2006","journal-title":"Biochem. Cell Biol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/ph9040061","article-title":"Lactoferrin from milk: nutraceutical and pharmacological properties","volume":"9","author":"Giansanti","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.lfs.2024.123340_bb0200","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1625\/jcam.9.121","article-title":"Questionnaire survey on the subjective effects of a lactoferrin supplement","author":"Oda","year":"2012","journal-title":"Japanese Journal of Complementary and Alternative Medicine"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0205","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0166-3542(01)00195-4","article-title":"Antiviral activities of lactoferrin","volume":"52","author":"Van der Strate","year":"2001","journal-title":"Antivir. Res."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0210","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.3390\/molecules27092941","article-title":"The lactoferrin phenomenon\u2014a miracle molecule","volume":"27","author":"Kowalczyk","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0215","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3390\/ph16020214","article-title":"Lactoferrin as a component of pharmaceutical preparations: an experimental focus","volume":"16","author":"Guzm\u00e1n-Mej\u00eda","year":"2023","journal-title":"Pharmaceuticals"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/pharmaceutics14010185","article-title":"Formulation, characterization, and cytotoxicity evaluation of lactoferrin functionalized lipid nanoparticles for riluzole delivery to the brain","volume":"14","author":"Teixeira","year":"2022","journal-title":"Pharmaceutics"},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0225","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/pharmaceutics14091862","article-title":"Lactoferrin-conjugated nanoparticles as new antivirals","volume":"14","author":"Krzyzowska","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.lfs.2024.123340_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.129325","article-title":"Formulation of lactoferrin decorated dextran based chitosan-coated europium metal-organic framework for targeted delivery of curcumin","volume":"259","author":"Nangare","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2024.123340_bb0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijbiomac.2022.08.067","article-title":"Therapeutic efficacy of Nano-formulation of lactoperoxidase and lactoferrin via promoting immunomodulatory and apoptotic effects","volume":"220","author":"El-Fakharany","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"1\u20132","key":"10.1016\/j.lfs.2024.123340_bb0240","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ijpharm.2007.05.032","article-title":"Formulation and evaluation of lactoferrin bioadhesive tablets","volume":"343","author":"Takahashi","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb0245","doi-asserted-by":"crossref","first-page":"9916","DOI":"10.3168\/jds.2017-13250","article-title":"A 100-year review: progress on the chemistry of milk and its components","volume":"100","author":"Lucey","year":"2017","journal-title":"J. Dairy Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0250","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1139\/o2012-018","article-title":"Lactoferrin\u201350 years on","volume":"90","author":"Brock","year":"2012","journal-title":"Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0255","doi-asserted-by":"crossref","first-page":"457","DOI":"10.17221\/1978-VETMED","article-title":"Lactoferrin: a review","volume":"53","author":"Adlerova","year":"2008","journal-title":"Vet. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1432-1033.1991.tb15801.x","article-title":"Molecular cloning and sequence analysis of bovine lactotransferrin","volume":"196","author":"Pierce","year":"1991","journal-title":"Eur. J. Biochem."},{"issue":"17","key":"10.1016\/j.lfs.2024.123340_bb0265","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.1093\/nar\/18.17.5288","article-title":"Complete nucleotide sequence of human mammary gland lactoferrin","volume":"18","author":"Rey","year":"1990","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.lfs.2024.123340_bb0270","first-page":"43","article-title":"Iron transport mechanism of lactoferrin and its application in food processing","author":"Fu","year":"2023","journal-title":"Food Sci. Technol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0275","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1080\/10408398.2017.1381583","article-title":"Lactoferrin: structure, function, denaturation and digestion","volume":"59","author":"Wang","year":"2019","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0280","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.170.2.415","article-title":"Multiple molecular forms of human lactoferrin. Identification of a class of lactoferrins that possess ribonuclease activity and lack iron-binding capacity","volume":"170","author":"Furmanski","year":"1989","journal-title":"J. Exp. Med."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0285","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/ijms18091985","article-title":"Lactoferrin: a natural glycoprotein involved in iron and inflammatory homeostasis","volume":"18","author":"Rosa","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0290","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3390\/pharmaceutics15041056","article-title":"Time to kill and time to heal: the multifaceted role of lactoferrin and lactoferricin in host defense","volume":"15","author":"Ohradanova-Repic","year":"2023","journal-title":"Pharmaceutics"},{"issue":"14","key":"10.1016\/j.lfs.2024.123340_bb0295","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.3390\/ijms21144903","article-title":"Lactoferrin as protective natural barrier of respiratory and intestinal mucosa against coronavirus infection and inflammation","volume":"21","author":"Campione","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123340_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.666600","article-title":"Lactoferrin against SARS-CoV-2: in vitro and in silico evidences","volume":"12","author":"Campione","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.106118","article-title":"Lactoferrin as potential preventative and adjunct treatment for COVID-19","volume":"56","author":"Chang","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0310","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.biochi.2008.04.006","article-title":"Effect of lactoferrin on enteric pathogens","volume":"91","author":"Ochoa","year":"2009","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0315","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/jcim-2014-0039","article-title":"Bovine colostrum: an emerging nutraceutical","volume":"12","author":"Bagwe","year":"2015","journal-title":"J. Complement. Integr. Med."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0320","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1139\/bcb-2016-0060","article-title":"Factors affecting lactoferrin concentration in human milk: how much do we know?","volume":"95","author":"Villavicencio","year":"2017","journal-title":"Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0325","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/cncr.23519","article-title":"Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma","volume":"113","author":"Jonasch","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0330","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2174\/138920309788922234","article-title":"Molecular and biotechnological advances in milk proteins in relation to human health","volume":"10","author":"Kanwar","year":"2009","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.lfs.2024.123340_bb0335","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s40124-013-0028-2","article-title":"Immunologic factors in human milk and disease prevention in the preterm infant","volume":"1","author":"Gregory","year":"2013","journal-title":"Curr. Pediatr. Rep."},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb0340","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1177\/0022034515605270","article-title":"Osteopontin in immune-mediated diseases","volume":"94","author":"Rittling","year":"2015","journal-title":"J. Dent. Res."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0345","doi-asserted-by":"crossref","first-page":"870","DOI":"10.3390\/nu13030870","article-title":"In the age of viral pandemic, can ingredients inspired by human milk and infant nutrition be repurposed to support the immune system?","volume":"13","author":"Brink","year":"2021","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0350","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104136","article-title":"Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication","volume":"25","author":"Lai","year":"2022","journal-title":"iScience"},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb0355","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/1471-0528.16362","article-title":"Maternal transmission of SARS-COV-2 to the neonate, and possible routes for such transmission: a systematic review and critical analysis","volume":"127","author":"Walker","year":"2020","journal-title":"BJOG"},{"issue":"6","key":"10.1016\/j.lfs.2024.123340_bb0360","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/154405910208100612","article-title":"Salivary defense factors in herpes simplex virus infection","volume":"81","author":"V\u00e4limaa","year":"2002","journal-title":"J. Dent. Res."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0365","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/MPG.0000000000002071","article-title":"Anti-cytomegalovirus activity in human milk and colostrum from mothers of preterm infants","volume":"67","author":"Donalisio","year":"2018","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb0370","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/adc.65.8.861","article-title":"Antiviral and antibacterial lipids in human milk and infant formula feeds","volume":"65","author":"Isaacs","year":"1990","journal-title":"Arch. Dis. Child."},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb0375","doi-asserted-by":"crossref","first-page":"3798","DOI":"10.3390\/nu13113798","article-title":"Diverse immune effects of bovine colostrum and benefits in human health and disease","volume":"13","author":"Ghosh","year":"2021","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0380","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.3390\/nu9091034","article-title":"Changes in fatty acid composition of human milk in response to cold-like symptoms in the lactating mother and infant","volume":"9","author":"Gardner","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0385","doi-asserted-by":"crossref","first-page":"694","DOI":"10.3390\/nu13020694","article-title":"The antiviral properties of human milk: a multitude of defence tools from mother nature","volume":"13","author":"Morniroli","year":"2021","journal-title":"Nutrients"},{"issue":"6","key":"10.1016\/j.lfs.2024.123340_bb0390","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1651-2227.1977.tb07978.x","article-title":"Iron absorption from infant milk formula and the optimal level of iron supplementation","volume":"66","author":"Saarinen","year":"1977","journal-title":"Acta Paediatr."},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb0395","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/ped.13671","article-title":"Baby-led complementary feeding: randomized controlled study","volume":"60","author":"Dogan","year":"2018","journal-title":"Pediatr. Int."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0400","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.nu.15.070195.000521","article-title":"Lactoferrin: molecular structure and biological function","volume":"15","author":"L\u00f6nnerdal","year":"1995","journal-title":"Annu. Rev. Nutr."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.antiviral.2005.03.005","article-title":"Lactoferrin inhibits enterovirus 71 infection by binding to VP1 protein and host cells","volume":"67","author":"Weng","year":"2005","journal-title":"Antivir. Res."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0410","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1747-0285.2008.00715.x","article-title":"Helical peptides derived from lactoferrin bind hepatitis C virus envelope protein E2","volume":"72","author":"Beleid","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.lfs.2024.123340_bb0415","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1007\/s00018-005-5372-0","article-title":"Lactoferrin: lactoferrin: an important host defence against microbial and viral attack","volume":"62","author":"Valenti","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2024.123340_bb0420","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1007\/s00705-021-04993-4","article-title":"Lactoferrin affects rhinovirus B-14 entry into H1-HeLa cells","volume":"166","author":"Denani","year":"2021","journal-title":"Arch. Virol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0425","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7883\/yoken1952.47.73","article-title":"Inhibition with lactoferrin of in vitro infection with human herpes virus","volume":"47","author":"Hasegawa","year":"1994","journal-title":"Jpn. J. Med. Sci. Biol."},{"key":"10.1016\/j.lfs.2024.123340_bb0430","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1023\/A:1013655315969","article-title":"The antiviral protein human lactoferrin is distributed in the body to cytomegalovirus (CMV) infection-prone cells and tissues","volume":"19","author":"Beljaars","year":"2002","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0435","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1089\/aid.1996.12.769","article-title":"Antiviral effects of milk proteins: acylation results in polyanionic compounds with potent activity against human immunodeficiency virus types 1 and 2 in vitro","volume":"12","author":"Swart","year":"1996","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0440","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S1357-2725(98)00066-1","article-title":"Antiviral effect of bovine lactoferrin saturated with metal ions on early steps of human immunodeficiency virus type 1 infection","volume":"30","author":"Puddu","year":"1998","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0445","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1006\/bbrc.1998.8481","article-title":"Lactoferrin markedly inhibits hepatitis C virus infection in cultured human hepatocytes","volume":"245","author":"Ikeda","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb0450","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1099\/00222615-47-11-1015","article-title":"Effect of compounds with antibacterial activities in human milk on respiratory syncytial virus and cytomegalovirus in vitro","volume":"47","author":"Portelli","year":"1998","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.lfs.2024.123340_bb0455","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s007050070077","article-title":"In vitro antiviral activity of lactoferrin and ribavirin upon hantavirus","volume":"145","author":"Murphy","year":"2000","journal-title":"Arch. Virol."},{"key":"10.1016\/j.lfs.2024.123340_bb0460","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10534-010-9323-3","article-title":"Bovine lactoferrin inhibits influenza a virus induced programmed cell death in vitro","volume":"23","author":"Pietrantoni","year":"2010","journal-title":"Biometals"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0465","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/22221751.2021.1888660","article-title":"The in vitro antiviral activity of lactoferrin against common human coronaviruses and SARS-CoV-2 is mediated by targeting the heparan sulfate co-receptor","volume":"10","author":"Hu","year":"2021","journal-title":"Emerg. Microbes. Infect."},{"issue":"15","key":"10.1016\/j.lfs.2024.123340_bb0470","first-page":"4184","article-title":"Protective influence of lactoferrin on mice infected with the polycythemia-inducing strain of friend virus complex","volume":"47","author":"Lu","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2024.123340_bb0475","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3389\/fped.2020.00233","article-title":"Effects of lactoferrin-fortified formula on acute gastrointestinal symptoms in children aged 12\u201332 months: a randomized, double-blind, placebo-controlled trial","volume":"8","author":"Motoki","year":"2020","journal-title":"Front. Pediatr."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0480","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jmii.2020.02.010","article-title":"Effects of lactoferrin on infectious diseases in Japanese summer: a randomized, double-blinded, placebo-controlled trial","volume":"54","author":"Oda","year":"2021","journal-title":"J. Microbiol. Immunol. Infect."},{"issue":"38","key":"10.1016\/j.lfs.2024.123340_bb0485","doi-asserted-by":"crossref","first-page":"23661","DOI":"10.1016\/S0021-9258(17)31566-1","article-title":"Delineation of the glycosaminoglycan-binding site in the human inflammatory response protein lactoferrin","volume":"269","author":"Mann","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.lfs.2024.123340_bb0490","doi-asserted-by":"crossref","first-page":"385","DOI":"10.3389\/fimmu.2013.00385","article-title":"Human immunodeficiency virus and heparan sulfate: from attachment to entry inhibition","volume":"4","author":"Connell","year":"2013","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0495","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0166-3542(01)00197-8","article-title":"Antiadenovirus activity of milk proteins: lactoferrin prevents viral infection","volume":"53","author":"Arnold","year":"2002","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0500","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jmv.10337","article-title":"Heparin-interacting sites of bovine lactoferrin are involved in anti-adenovirus activity","volume":"69","author":"Di Biase","year":"2003","journal-title":"J. Med. Virol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0505","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1128\/JVI.01995-06","article-title":"Adenoviruses use lactoferrin as a bridge for CAR-independent binding to and infection of epithelial cells","volume":"81","author":"Johansson","year":"2007","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0510","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.3390\/ijms18091957","article-title":"Bovine lactoferrin inhibits dengue virus infectivity by interacting with heparan sulfate, low-density lipoprotein receptor, and DC-SIGN","volume":"18","author":"Chen","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1759-9","article-title":"Serum neutrophil gelatinase-associated lipocalin and resistin are associated with dengue infection in adults","volume":"16","author":"Liu","year":"2016","journal-title":"BMC Infect. Dis."},{"issue":"7","key":"10.1016\/j.lfs.2024.123340_bb0520","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1099\/jgv.0.000849","article-title":"Bovine lactoferrin activity against chikungunya and Zika viruses","volume":"98","author":"Carvalho","year":"2017","journal-title":"J. Gen. Virol."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb0525","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1086\/343809","article-title":"Lactoferrin inhibits enterovirus 71 infection of human embryonal rhabdomyosarcoma cells in vitro","volume":"186","author":"Lin","year":"2002","journal-title":"J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0530","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.antiviral.2005.10.006","article-title":"Bovine lactoferrin peptidic fragments involved in inhibition of echovirus 6 in vitro infection","volume":"69","author":"Pietrantoni","year":"2006","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0535","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000336178","article-title":"Inhibition of Epstein-Barr virus infection by lactoferrin","volume":"4","author":"Zheng","year":"2012","journal-title":"J. Innate Immun."},{"issue":"6","key":"10.1016\/j.lfs.2024.123340_bb0540","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1292\/jvms.63.637","article-title":"Characterization of in vitro and in vivo antiviral activity of lactoferrin and ribavirin upon hantavirus","volume":"63","author":"Murphy","year":"2001","journal-title":"J. Vet. Med. Sci."},{"issue":"2\u20133","key":"10.1016\/j.lfs.2024.123340_bb0545","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0166-3542(95)00840-3","article-title":"Lactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells","volume":"29","author":"Marchetti","year":"1996","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2024.123340_bb0550","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1023\/A:1009217709851","article-title":"Metal complexes of bovine lactoferrin inhibit in vitro replication of herpes simplex virus type 1 and 2","volume":"11","author":"Marchetti","year":"1998","journal-title":"Biometals"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0555","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/095632020101200206","article-title":"Enhancement of anti-herpetic activity of glycyrrhizic acid by physiological proteins","volume":"12","author":"Lampis","year":"2001","journal-title":"Antivir. Chem. Chemother."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0560","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2004.05.005","article-title":"Lactoferrin inhibits human papillomavirus binding and uptake in vitro","volume":"64","author":"Drobni","year":"2004","journal-title":"Antivir. Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0565","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.bbrc.2013.04.013","article-title":"The protective effects of lactoferrin against murine norovirus infection through inhibition of both viral attachment and replication","volume":"434","author":"Ishikawa","year":"2013","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0570","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1386-6346(02)00088-8","article-title":"Lactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes","volume":"24","author":"Hara","year":"2002","journal-title":"Hepatol. Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0575","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1179\/2047773212Y.0000000004","article-title":"Bovine lactoferrin-derived peptides as novel broad-spectrum inhibitors of influenza virus","volume":"106","author":"Ammendolia","year":"2012","journal-title":"Pathog. Glob. Health."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0580","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1139\/o11-072","article-title":"Bovine lactoferrin: involvement of metal saturation and carbohydrates in the inhibition of influenza virus infection","volume":"90","author":"Pietrantoni","year":"2012","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123340_bb0585","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.virol.2014.01.022","article-title":"Inhibition of Mayaro virus infection by bovine lactoferrin","volume":"452","author":"Carvalho","year":"2014","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0590","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2006.05.008","article-title":"Lactoferrin inhibits early steps of human BK polyomavirus infection","volume":"72","author":"Longhi","year":"2006","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0595","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3390\/v7020480","article-title":"Bovine lactoferrin inhibits Toscana virus infection by binding to heparan sulphate","volume":"7","author":"Pietrantoni","year":"2015","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0600","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/s41392-022-00996-y","article-title":"COVID-19 vaccine development: milestones, lessons and prospects","volume":"7","author":"Li","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb0605","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1002\/jmv.25966","article-title":"Clinical features of patients with coronavirus disease 2019 from a designated hospital in Beijing, China","volume":"92","author":"Sun","year":"2020","journal-title":"J. Med. Virol."},{"issue":"09","key":"10.1016\/j.lfs.2024.123340_bb0610","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/CM9.0000000000000797","article-title":"Repurposing of clinically approved drugs for treatment of coronavirus disease 2019 in a 2019-novel coronavirus-related coronavirus model","volume":"133","author":"Fan","year":"2020","journal-title":"Chin. Med. J."},{"issue":"24","key":"10.1016\/j.lfs.2024.123340_bb0615","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.3390\/nu14245274","article-title":"Can lactoferrin, a natural mammalian milk protein, assist in the battle against COVID-19?","volume":"14","author":"Einerhand","year":"2022","journal-title":"Nutrients"},{"issue":"10334","key":"10.1016\/j.lfs.2024.123340_bb0620","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(21)02796-3","article-title":"Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020\u201321","volume":"399","author":"Wang","year":"2022","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0625","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.3168\/jds.2021-21247","article-title":"Evaluating the in vitro efficacy of bovine lactoferrin products against SARS-CoV-2 variants of concern","volume":"105","author":"Wotring","year":"2022","journal-title":"J. Dairy Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0630","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10534-022-00477-3","article-title":"Bovine lactoferrin for the prevention of COVID-19 infection in health care personnel: a double-blinded randomized clinical trial (LF-COVID)","volume":"36","author":"Navarro","year":"2023","journal-title":"Biometals"},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0635","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1021\/acsptsci.0c00081","article-title":"Potential role of peptide-based antiviral therapy against SARS-CoV-2 infection","volume":"3","author":"Maiti","year":"2020","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.lfs.2024.123340_bb0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.120566","article-title":"Integrated computational approach towards identification of HSPG and ACE2 mimicking moieties for SARS-CoV-2 inhibition","volume":"367","author":"Sreekumar","year":"2022","journal-title":"J. Mol. Liq."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb0645","doi-asserted-by":"crossref","first-page":"5436","DOI":"10.3390\/ijms23105436","article-title":"Lactoferrin inhibition of the complex formation between ACE2 receptor and SARS CoV-2 recognition binding domain","volume":"23","author":"Piacentini","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0650","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28281","article-title":"Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model","volume":"95","author":"He","year":"2023","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0655","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/s41392-020-00408-z","article-title":"The effect of whey protein on viral infection and replication of SARS-CoV-2 and pangolin coronavirus in vitro","volume":"5","author":"Fan","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023710","article-title":"Inhibition of SARS pseudovirus cell entry by lactoferrin binding to heparan sulfate proteoglycans","volume":"6","author":"Lang","year":"2011","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0665","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01933-17","article-title":"Entry of human coronavirus NL63 into the cell","volume":"92","author":"Milewska","year":"2018","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104136","article-title":"Identified human breast milk compositions effectively inhibit SARS-CoV-2 and variants infection and replication","volume":"25","author":"Lai","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.lfs.2024.123340_bb0675","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111228","article-title":"The role of iron in the pathogenesis of COVID-19 and possible treatment with lactoferrin and other iron chelators","volume":"136","author":"Habib","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2024.123340_bb0680","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2020.589736","article-title":"Anti-infective, anti-inflammatory, and immunomodulatory properties of breast milk factors for the protection of infants in the pandemic from COVID-19","volume":"8","author":"Quitadamo","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.lfs.2024.123340_bb0685","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107571","article-title":"The potential for Lactoferrin to reduce SARS-CoV-2 induced cytokine storm","volume":"95","author":"Zimecki","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.lfs.2024.123340_bb0690","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.958581","article-title":"Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin","volume":"13","author":"Ohradanova-Repic","year":"2022","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.lfs.2024.123340_bb0695","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.3390\/ijms241310529","article-title":"Testing antimicrobial properties of human Lactoferrin-derived fragments","volume":"24","author":"Ostr\u00f3wka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.lfs.2024.123340_bb0700","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.3390\/cells10071810","article-title":"A review on lactoferrin and central nervous system diseases","volume":"10","author":"Li","year":"2021","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0705","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1080\/19390211.2021.1922567","article-title":"Lactoferrin for mental health: neuro-redox regulation and neuroprotective effects across the blood-brain barrier with special reference to neuro-COVID-19","volume":"20","author":"Naidu","year":"2021","journal-title":"J. Diet. Suppl."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0710","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41579-022-00713-0","article-title":"SARS-CoV-2 pathogenesis","volume":"20","author":"Lamers","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"issue":"32","key":"10.1016\/j.lfs.2024.123340_bb0715","doi-asserted-by":"crossref","first-page":"11665","DOI":"10.12998\/wjcc.v10.i32.11665","article-title":"Combined use of lactoferrin and vitamin D as a preventive and therapeutic supplement for SARS-CoV-2 infection: current evidence","volume":"10","author":"Cipriano","year":"2022","journal-title":"World J. Clin. Cases"},{"issue":"20","key":"10.1016\/j.lfs.2024.123340_bb0720","doi-asserted-by":"crossref","first-page":"10985","DOI":"10.3390\/ijerph182010985","article-title":"Lactoferrin as antiviral treatment in COVID-19 management: preliminary evidence","volume":"18","author":"Campione","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0725","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10534-022-00427-z","article-title":"An overview on in vitro and in vivo antiviral activity of lactoferrin: its efficacy against SARS-CoV-2 infection","volume":"36","author":"Rosa","year":"2023","journal-title":"Biometals"},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb0730","article-title":"Lactoferrin Against SARS-CoV-2: In Vitro and In Silico Evidences","volume":"17","author":"Campione","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.lfs.2024.123340_bb0735","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.3389\/fimmu.2018.02123","article-title":"Efficacy of lactoferrin oral administration in the treatment of anemia and anemia of inflammation in pregnant and non-pregnant women: an interventional study","volume":"9","author":"Lepanto","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0740","first-page":"8","article-title":"Liposomal lactoferrin as potential preventative and cure for COVID-19","volume":"8","author":"Serrano","year":"2020","journal-title":"Int. J. Res. Health Sci"},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb0745","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3390\/medicina57080842","article-title":"The Prospect of lactoferrin use as adjunctive agent in management of SARS-CoV-2 patients: a randomized pilot study","volume":"57","author":"Algahtani","year":"2021","journal-title":"Medicina"},{"issue":"18","key":"10.1016\/j.lfs.2024.123340_bb0750","doi-asserted-by":"crossref","first-page":"4276","DOI":"10.3390\/jcm10184276","article-title":"Ambulatory COVID-19 patients treated with lactoferrin as a supplementary antiviral agent: a preliminary study","volume":"10","author":"Rosa","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.lfs.2024.123340_bb0755","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.3389\/fimmu.2020.570122","article-title":"Immune-boosting, antioxidant and anti-inflammatory food supplements targeting pathogenesis of COVID-19","volume":"11","author":"Mrityunjaya","year":"2020","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0760","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1002\/jmv.27019","article-title":"Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19","volume":"93","author":"Muralidar","year":"2021","journal-title":"J. Med. Virol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0765","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.3390\/nu14051000","article-title":"The role of nutrients in prevention, treatment and post-coronavirus disease-2019 (COVID-19)","volume":"14","author":"Motti","year":"2022","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0770","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3390\/v15040972","article-title":"Liposomal lactoferrin exerts antiviral activity against HCoV-229E and SARS-CoV-2 pseudoviruses in vitro","volume":"15","author":"Andreu","year":"2023","journal-title":"Viruses"},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb0775","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.3390\/molecules25081997","article-title":"Viral hepatitis and iron dysregulation: molecular pathways and the role of lactoferrin","volume":"25","author":"Mancinelli","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.lfs.2024.123340_bb0780","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.phrs.2018.02.030","article-title":"Dosing ribavirin in hepatitis E-infected solid organ transplant recipients","volume":"130","author":"De Winter","year":"2018","journal-title":"Pharmacol. Res."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb0785","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1128\/jvi.71.8.5997-6002.1997","article-title":"Hepatitis C virus envelope proteins bind lactoferrin","volume":"71","author":"Yi","year":"1997","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb0790","doi-asserted-by":"crossref","first-page":"4597","DOI":"10.1073\/pnas.72.11.4597","article-title":"Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles","volume":"72","author":"Summers","year":"1975","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0795","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.mi.31.100177.002041","article-title":"The genome of hepatitis B virus","volume":"31","author":"Robinson","year":"1977","journal-title":"Ann. Rev. Microbiol."},{"issue":"6","key":"10.1016\/j.lfs.2024.123340_bb0800","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1080\/21645515.2020.1847951","article-title":"Prevalence and factors associated with hepatitis B virus infection among household members: a cross-sectional study in Beijing","volume":"17","author":"Zhao","year":"2021","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.lfs.2024.123340_bb0805","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molimm.2022.05.017","article-title":"Studying antigen presentation in chronic hepatitis B infection and liver cancer for therapeutic vaccine design","volume":"150","author":"Buschow","year":"2022","journal-title":"Mol. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0810","doi-asserted-by":"crossref","first-page":"100766","DOI":"10.1016\/j.aohep.2022.100766","article-title":"Anti-hepatitis b virus activity of food nutrients and potential mechanisms of action","volume":"28","author":"Jose-Abrego","year":"2022","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.lfs.2024.123340_bb0815","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00430-008-0100-7","article-title":"Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin","volume":"198","author":"Li","year":"2009","journal-title":"Med. Microbiol. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0820","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jmv.23549","article-title":"Characterization of the anti-HBV activity of HLP1\u201323, a human lactoferrin-derived peptide","volume":"85","author":"Florian","year":"2013","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb0825","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.3390\/nu14081561","article-title":"Inhibition of in vitro infection of hepatitis B virus by human breastmilk","volume":"14","author":"Luo","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0830","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0055303","article-title":"Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb0835","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpediatrics.2011.72","article-title":"Breastfeeding of newborns by mothers carrying hepatitis B virus: a meta-analysis and systematic review","volume":"165","author":"Shi","year":"2011","journal-title":"Arch. Pediatr. Adolesc. Med."},{"issue":"24","key":"10.1016\/j.lfs.2024.123340_bb0840","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.87.24.9524","article-title":"Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis","volume":"87","author":"Kato","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0845","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1128\/jvi.70.5.3307-3312.1996","article-title":"Structure of the 3\u2019terminus of the hepatitis C virus genome","volume":"70","author":"Tanaka","year":"1996","journal-title":"J. Virol."},{"issue":"4902","key":"10.1016\/j.lfs.2024.123340_bb0850","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1126\/science.2523562","article-title":"Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome","volume":"244","author":"Choo","year":"1989","journal-title":"Science"},{"issue":"4902","key":"10.1016\/j.lfs.2024.123340_bb0855","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1126\/science.2496467","article-title":"An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis","volume":"244","author":"Kuo","year":"1989","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.lfs.2024.123340_bb0860","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1073\/pnas.87.17.6547","article-title":"Hepatitis C virus infection is associated with the development of hepatocellular carcinoma","volume":"87","author":"Saito","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0865","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1365-2893.2006.00785.x","article-title":"Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States","volume":"14","author":"Deuffic-Burban","year":"2007","journal-title":"J. Viral Hepat."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0870","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1053\/j.gastro.2016.04.003","article-title":"Hepatitis C virus resistance to direct-acting antiviral drugs in interferon-free regimens","volume":"151","author":"Pawlotsky","year":"2016","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb0875","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1093\/cid\/ciab334","article-title":"Hepatitis C virus direct-acting antiviral treatment adherence patterns and sustained viral response among people who inject drugs treated in opioid agonist therapy programs","volume":"73","author":"Heo","year":"2021","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0880","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1306218","article-title":"Daclatasvir plus sofosbuvir for previously treated or untreated chronic HCV infection","volume":"370","author":"Sulkowski","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0885","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.jhep.2019.10.010","article-title":"Simplified monitoring for hepatitis C virus treatment with glecaprevir plus pibrentasvir, a randomised non-inferiority trial","volume":"72","author":"Dore","year":"2020","journal-title":"J. Hepatol."},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb0890","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1074\/jbc.M207879200","article-title":"Identification of a lactoferrin-derived peptide possessing binding activity to hepatitis C virus E2 envelope protein","volume":"278","author":"Nozaki","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0895","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-9-201","article-title":"Anti-infectivity of camel polyclonal antibodies against hepatitis C virus in Huh7. 5 hepatoma","volume":"9","author":"El-Fakharany","year":"2012","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6882-14-219","article-title":"Screening the anti infectivity potentials of native N-and C-lobes derived from the camel lactoferrin against hepatitis C virus","volume":"14","author":"Redwan","year":"2014","journal-title":"BMC Complement. Altern. Med."},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb0905","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/j.1440-1746.2007.04858.x","article-title":"Effect of lactoferrin in patients with chronic hepatitis C: combination therapy with interferon and ribavirin","volume":"22","author":"Kaito","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb0910","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S1386-6346(02)00279-6","article-title":"Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months","volume":"25","author":"Ishii","year":"2003","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.lfs.2024.123340_bb0915","series-title":"Microbiology of Waterborne Diseases","first-page":"493","article-title":"Enterovirus","author":"Yates","year":"2014"},{"key":"10.1016\/j.lfs.2024.123340_bb0920","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coviro.2020.06.006","article-title":"Enterovirus infection and acute flaccid myelitis","volume":"40","author":"Uprety","year":"2020","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.lfs.2024.123340_bb0925","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jcv.2018.01.008","article-title":"Recommendations for enterovirus diagnostics and characterisation within and beyond Europe","volume":"101","author":"Harvala","year":"2018","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.lfs.2024.123340_bb0930","series-title":"Handbook of Clinical Neurology","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/B978-0-444-53488-0.00018-3","article-title":"Enterovirus\/picornavirus infections","volume":"123","author":"Jubelt","year":"2014"},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0935","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.apsb.2021.08.017","article-title":"Enterovirus A71 antivirals: past, present, and future","volume":"12","author":"Wang","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0940","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.lfs.2024.123340_bb0945","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF01317504","article-title":"Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria","volume":"60","author":"Chumakov","year":"1979","journal-title":"Arch. Virol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb0950","first-page":"205","article-title":"Enterovirus 71: the virus, its infections and outbreaks","volume":"33","author":"Ho","year":"2000","journal-title":"Journal of Microbiology, Immunology, and Infection= Wei Mian yu gan ran za zhi"},{"issue":"7","key":"10.1016\/j.lfs.2024.123340_bb0955","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00006454-198807000-00007","article-title":"Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement","volume":"7","author":"Gilbert","year":"1988","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0960","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1080\/00365540110077119","article-title":"Clinical manifestations and laboratory assessment in an enterovirus 71 outbreak in southern Taiwan","volume":"34","author":"Li","year":"2002","journal-title":"Scand. J. Infect. Dis."},{"issue":"13","key":"10.1016\/j.lfs.2024.123340_bb0965","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1056\/NEJM199909233411301","article-title":"An epidemic of enterovirus 71 infection in Taiwan","volume":"341","author":"Ho","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2024.123340_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170443","article-title":"Antiviral peptides against enterovirus A71 causing hand, foot and mouth disease","volume":"136","author":"Lalani","year":"2021","journal-title":"Peptides"},{"issue":"7","key":"10.1016\/j.lfs.2024.123340_bb0975","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0969-2126(96)00084-6","article-title":"Poliovirus biology","volume":"4","author":"Minor","year":"1996","journal-title":"Structure"},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0980","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2672.2003.02071.x","article-title":"The effect of bovine lactoferrin and lactoferricin B on the ability of feline calicivirus (a norovirus surrogate) and poliovirus to infect cell cultures","volume":"95","author":"McCann","year":"2003","journal-title":"J. Appl. Microbiol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb0985","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/0022-1317-78-1-1","article-title":"Classification of enteroviruses based on molecular and biological properties","volume":"78","author":"Hyypi\u00e4","year":"1997","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb0990","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/modpathol.3880260","article-title":"Fatal neonatal echovirus 6 infection: autopsy case report and review of the literature","volume":"14","author":"Ventura","year":"2001","journal-title":"Mod. Pathol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb0995","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3476(84)80944-0","article-title":"Epidemiology of neonatal enterovirus infection","volume":"104","author":"Jenista","year":"1984","journal-title":"J. Pediatr."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1000","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.ijantimicag.2005.02.011","article-title":"Inhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro","volume":"25","author":"Tinari","year":"2005","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1005","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.antiviral.2006.09.002","article-title":"Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides","volume":"73","author":"Ammendolia","year":"2007","journal-title":"Antivir. Res."},{"issue":"7","key":"10.1016\/j.lfs.2024.123340_bb1010","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nutres.2012.06.006","article-title":"Bovine lactoferrin digested with human gastrointestinal enzymes inhibits replication of human echovirus 5 in cell culture","volume":"32","author":"Furlund","year":"2012","journal-title":"Nutr. Res."},{"key":"10.1016\/j.lfs.2024.123340_bb1015","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/B978-0-12-815422-9.00011-5","article-title":"Rhinovirus RNA polymerase: structure, function, and inhibitors","author":"Nirwan","year":"2019","journal-title":"Viral Polymerases"},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1020","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1099\/0022-1317-49-8-719","article-title":"Effect of antimicrobial factors in human milk on rhinoviruses and milk-borne cytomegalovirus in vitro","volume":"49","author":"Clarke","year":"2000","journal-title":"J. Med. Microbiol."},{"key":"10.1016\/j.lfs.2024.123340_bb1025","series-title":"Seminars in Respiratory and Critical Care Medicine","article-title":"Adenovirus","author":"Lynch","year":"2011"},{"key":"10.1016\/j.lfs.2024.123340_bb1030","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.685218","article-title":"Lactoferrin retargets human adenoviruses to TLR4 to induce an abortive NLRP3-associated pyroptotic response in human phagocytes","volume":"12","author":"Ch\u00e9neau","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S1286-4579(00)01351-4","article-title":"The 1918 Spanish influenza: integrating history and biology","volume":"3","author":"Reid","year":"2001","journal-title":"Microbes Infect."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1040","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nsmb.1779","article-title":"Structures of influenza a proteins and insights into antiviral drug targets","volume":"17","author":"Das","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1045","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1601.091304","article-title":"Oseltamivir-and amantadine-resistant influenza virus A (H1N1)","volume":"16","author":"Cheng","year":"2010","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1050","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/v11010051","article-title":"Bovine lactoferrin prevents influenza A virus infection by interfering with the fusogenic function of viral hemagglutinin","volume":"11","author":"Superti","year":"2019","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-10492-x","article-title":"Lactoferrin-derived peptides active towards influenza: identification of three potent tetrapeptide inhibitors","volume":"7","author":"Scala","year":"2017","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1060","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0166-3542(02)00214-0","article-title":"Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir","volume":"58","author":"Andersen","year":"2003","journal-title":"Antivir. Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1065","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0166-3542(02)00211-5","article-title":"Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro","volume":"58","author":"van der Strate","year":"2003","journal-title":"Antivir. Res."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1070","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3201\/eid1208.060264","article-title":"Qinghai-like H5N1 from domestic cats, northern Iraq","volume":"12","author":"Yingst","year":"2006","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.lfs.2024.123340_bb1075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-7-330","article-title":"Effectiveness of esterified whey proteins fractions against Egyptian Lethal Avian Influenza A (H5N1)","volume":"7","author":"Taha","year":"2010","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.83","article-title":"Rotavirus infection","volume":"3","author":"Crawford","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"13","key":"10.1016\/j.lfs.2024.123340_bb1085","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S1286-4579(01)01475-7","article-title":"Pathogenesis of rotavirus diarrhea","volume":"3","author":"Lundgren","year":"2001","journal-title":"Microbes Infect."},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb1090","doi-asserted-by":"crossref","first-page":"4088","DOI":"10.3168\/jds.S0022-0302(04)73551-1","article-title":"Inhibitory effects of human and bovine milk constituents on rotavirus infections","volume":"87","author":"Kvistgaard","year":"2004","journal-title":"J. Dairy Sci."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1095","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.4014\/jmb.2106.06044","article-title":"Bovine Lactoferricin Induces Intestinal Epithelial Cell Activation through Phosphorylation of FAK and Paxillin and Prevents Rotavirus Infection","volume":"31","author":"Jeong","year":"2021","journal-title":"J. Microbiol. Biotechnol."},{"key":"10.1016\/j.lfs.2024.123340_bb1100","series-title":"Antigenic and Biologic Differences in Herpesvirus Hominis. Progress in Medical Virology. Fortschritte der medizinischen Virusforschung. Progres en virologie medicale","first-page":"110","volume":"10","author":"Nahmias","year":"1968"},{"issue":"7","key":"10.1016\/j.lfs.2024.123340_bb1105","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1099\/0022-1317-69-7-1531","article-title":"The complete DNA sequence of the long unique region in the genome of herpes simplex virus type 1","volume":"69","author":"McGeoch","year":"1988","journal-title":"J. Gen. Virol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1110","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1128\/JVI.72.3.2010-2021.1998","article-title":"The genome sequence of herpes simplex virus type 2","volume":"72","author":"Dolan","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.lfs.2024.123340_bb1115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.preteyeres.2012.08.002","article-title":"Herpes keratitis","volume":"32","author":"Rowe","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"issue":"24","key":"10.1016\/j.lfs.2024.123340_bb1120","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1007\/s00018-005-5228-7","article-title":"Anti herpes simplex virus activity of lactoferrin\/lactoferricin\u2013an example of antiviral activity of antimicrobial protein\/peptide","volume":"62","author":"Jenssen","year":"2005","journal-title":"Cell. Mol. Life. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1125","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.antiviral.2007.07.005","article-title":"Bovine lactoferrin prevents the entry and intercellular spread of herpes simplex virus type 1 in Green Monkey Kidney cells","volume":"76","author":"Ammendolia","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2024.123340_bb1130","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/BF01322673","article-title":"Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea","volume":"140","author":"Fujihara","year":"1995","journal-title":"Arch. Virol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1135","doi-asserted-by":"crossref","first-page":"678","DOI":"10.3390\/v5020678","article-title":"Directional spread of alphaherpesviruses in the nervous system","volume":"5","author":"Kramer","year":"2013","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1140","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.biochi.2008.05.016","article-title":"Bovine lactoferrin and lactoferricin interfere with intracellular trafficking of Herpes simplex virus-1","volume":"91","author":"Marr","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.lfs.2024.123340_bb1145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-422X-6-53","article-title":"Human lactoferrin but not lysozyme neutralizes HSV-1 and inhibits HSV-1 replication and cell-to-cell spread","volume":"6","author":"V\u00e4limaa","year":"2009","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/bbrc.1999.1318","article-title":"Bovine lactoferrin peptidic fragments involved in inhibition of herpes simplex virus type 1 infection","volume":"264","author":"Siciliano","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1155","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2471\/BLT.19.237149","article-title":"Herpes simplex virus: global infection prevalence and incidence estimates, 2016","volume":"98","author":"James","year":"2020","journal-title":"Bull. World Health Organ."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00126334-200404150-00001","article-title":"The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics","volume":"35","author":"Corey","year":"2004","journal-title":"J. Acquir. Immune. Defic. Syndr."},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb1165","first-page":"928","article-title":"Genital herpes: a review","volume":"93","author":"Groves","year":"2016","journal-title":"Am. Fam. Physician"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/jiy178","article-title":"Sexually transmitted bedfellows: exquisite association between HIV and herpes simplex virus type 2 in 21 communities in southern Africa in the HIV prevention trials network 071 (PopART) study","volume":"218","author":"Bradley","year":"2018","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.3390\/microorganisms10010110","article-title":"Lactoferrin-functionalized noble metal nanoparticles as new antivirals for HSV-2 infection","volume":"10","author":"Krzyzowska","year":"2022","journal-title":"Microorganisms"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/vaccines11020206","article-title":"An insight into current treatment strategies, their limitations, and ongoing developments in vaccine technologies against herpes simplex infections","volume":"11","author":"Sharma","year":"2023","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.antiviral.2008.03.004","article-title":"Inhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin","volume":"79","author":"Jenssen","year":"2008","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.biochi.2008.04.015","article-title":"Glycosaminoglycans are not indispensable for the anti-herpes simplex virus type 2 activity of lactoferrin","volume":"91","author":"Marchetti","year":"2009","journal-title":"Biochimie"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0163-7258(03)00034-2","article-title":"The human cytomegalovirus","volume":"98","author":"Landolfo","year":"2003","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2024.123340_bb1200","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jpeds.2019.09.025","article-title":"Birth prevalence of congenital cytomegalovirus infection in HIV-exposed uninfected children in the era of combination antiretroviral therapy","volume":"216","author":"Purswani","year":"2020","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb1205","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.7150\/ijbs.58127","article-title":"Insight for immunotherapy of HCMV infection","volume":"17","author":"Long","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1210","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.antiviral.2004.05.002","article-title":"Inhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo","volume":"63","author":"Beljaars","year":"2004","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2024.123340_bb1215","first-page":"5","article-title":"HIV virology and pathogenetic mechanisms of infection: a brief overview","volume":"46","author":"Fanales-Belasio","year":"2010","journal-title":"Annali dell'Istituto superiore di sanita"},{"key":"10.1016\/j.lfs.2024.123340_bb1220","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/B:BIOM.0000027707.82911.be","article-title":"The antiviral activity of the milk protein lactoferrin against the human immunodeficiency virus type 1","volume":"17","author":"Berkhout","year":"2004","journal-title":"Biometals"},{"key":"10.1016\/j.lfs.2024.123340_bb1225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.peptides.2014.07.006","article-title":"A study of effects of peptide fragments of bovine and human lactoferrins on activities of three key HIV-1 enzymes","volume":"62","author":"Wong","year":"2014","journal-title":"Peptides"},{"key":"10.1016\/j.lfs.2024.123340_bb1230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/1874357901105010027","article-title":"Modulation of HIV binding to epithelial cells and HIV transfer from immature dendritic cells to CD4 T lymphocytes by human lactoferrin and its major exposed LF-33 peptide","volume":"5","author":"Carthagena","year":"2011","journal-title":"Open Virol. J."},{"issue":"19","key":"10.1016\/j.lfs.2024.123340_bb1235","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/S0024-3205(01)01311-X","article-title":"Inhibition of human immunodeficiency virus type 1 reverse transcriptase, protease and integrase by bovine milk proteins","volume":"69","author":"Ng","year":"2001","journal-title":"Life Sci."},{"issue":"22","key":"10.1016\/j.lfs.2024.123340_bb1240","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1016\/S0024-3205(00)00853-5","article-title":"First demonstration of an inhibitory activity of milk proteins against human immunodeficiency virus-1 reverse transcriptase and the effect of succinylation","volume":"67","author":"Wang","year":"2000","journal-title":"Life Sci."},{"issue":"16","key":"10.1016\/j.lfs.2024.123340_bb1245","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2174\/1381612033454810","article-title":"Antibacterial and antiviral effects of milk proteins and derivatives thereof","volume":"9","author":"Floris","year":"2003","journal-title":"Curr. Pharm. Des."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb1250","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140399","article-title":"Improved safety, bioavailability and pharmacokinetics of zidovudine through lactoferrin nanoparticles during oral administration in rats","volume":"10","author":"Kumar","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2024.123340_bb1255","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.ijbiomac.2020.07.167","article-title":"Lactoferrin, a unique molecule with diverse therapeutical and nanotechnological applications","volume":"164","author":"Sabra","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1260","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00126334-200402010-00015","article-title":"Breast-feeding and transmission of HIV-1","volume":"35","author":"John-Stewart","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.lfs.2024.123340_bb1265","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fped.2020.00248","article-title":"HIV-infected mothers who decide to breastfeed their infants under close supervision in Belgium: about two cases","volume":"8","author":"Bansaccal","year":"2020","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.lfs.2024.123340_bb1270","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3389\/fimmu.2017.01631","article-title":"Breastfeeding behaviors and the innate immune system of human milk: working together to protect infants against inflammation, HIV-1, and other infections","volume":"8","author":"Henrick","year":"2017","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1275","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijantimicag.2006.11.017","article-title":"Modulation of innate and adaptive immunity by lactoferrin in human immunodeficiency virus (HIV)-infected, antiretroviral therapy-na\u00efve children","volume":"29","author":"Zuccotti","year":"2007","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"6","key":"10.1016\/j.lfs.2024.123340_bb1280","doi-asserted-by":"crossref","DOI":"10.4269\/ajtmh.1957.6.1012","article-title":"Mayaro virus: a new human disease agent. II. Isolation from blood of patients in Trinidad, BWI","volume":"6","author":"Anderson","year":"1957","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1285","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/vbz.2011.0669","article-title":"Mayaro fever in the city of Manaus, Brazil, 2007\u20132008","volume":"12","author":"Mour\u00e3o","year":"2012","journal-title":"Vector-Borne and Zoonotic Diseases"},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb1290","doi-asserted-by":"crossref","first-page":"6186","DOI":"10.1128\/JCM.43.12.6186-6188.2005","article-title":"Toscana virus central nervous system infections in southern Italy","volume":"43","author":"Di Nicuolo","year":"2005","journal-title":"J. Clin. Microbiol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb1295","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1086\/381201","article-title":"Unusual presentation of life-threatening Toscana virus meningoencephalitis","volume":"38","author":"Baldelli","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1300","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1128\/CDLI.10.3.483-484.2003","article-title":"Serological survey of Toscana virus infections in a high-risk population in Italy","volume":"10","author":"Valassina","year":"2003","journal-title":"Clin. Vaccine Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1305","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0168-1702(93)90076-Y","article-title":"Toscana virus genomic L segment: molecular cloning, coding strategy and amino acid sequence in comparison with other negative strand RNA viruses","volume":"27","author":"Accardi","year":"1993","journal-title":"Virus Res."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb1310","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1099\/jgv.0.001318","article-title":"Updated classification of norovirus genogroups and genotypes","volume":"100","author":"Chhabra","year":"2019","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.lfs.2024.123340_bb1315","series-title":"50th Japanese society of clinical virology","first-page":"S56","article-title":"Prevention of norovirus infection in nursery school children by intake of lactoferrin-containing products","author":"Moriuchi","year":"2009"},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1320","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3201\/eid1908.130465","article-title":"Norovirus disease in the United States","volume":"19","author":"Hall","year":"2013","journal-title":"Emerg. Infect. Dis."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2334-11-105","article-title":"Modeling the variations in pediatric respiratory syncytial virus seasonal epidemics","volume":"11","author":"Leecaster","year":"2011","journal-title":"BMC Infect. Dis."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1330","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.12.2.298","article-title":"Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment","volume":"12","author":"Domachowske","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"issue":"4p2","key":"10.1016\/j.lfs.2024.123340_bb1335","doi-asserted-by":"crossref","first-page":"e691","DOI":"10.1111\/j.1399-3038.2010.01011.x","article-title":"Lower interleukin-8 levels in airway aspirates from breastfed infants with acute bronchiolitis","volume":"21","author":"Dixon","year":"2010","journal-title":"Pediatr. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1340","first-page":"221","article-title":"Long-term consequences of respiratory syncytial virus (RSV) bronchiolitis","volume":"1","author":"Bont","year":"2000","journal-title":"Paediatr. Respir. Rev."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb1345","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1128\/jvi.70.10.6634-6641.1996","article-title":"Recovery of infectious respiratory syncytial virus expressing an additional, foreign gene","volume":"70","author":"Bukreyev","year":"1996","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb1350","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3345\/kjp.2019.00402","article-title":"Positive association of breastfeeding on respiratory syncytial virus infection in hospitalized infants: a multicenter retrospective study","volume":"63","author":"Jang","year":"2020","journal-title":"Clin. Exp. Pediatr."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb1355","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1128\/CMR.3.4.376","article-title":"The dengue viruses","volume":"3","author":"Henchal","year":"1990","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.lfs.2024.123340_bb1360","first-page":"299","article-title":"Epidemiology of dengue: past, present and future prospects","author":"Murray","year":"2013","journal-title":"Clin. Epidemiol."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1365","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3390\/v12080829","article-title":"Dengue: a minireview","volume":"12","author":"Harapan","year":"2020","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1370","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/17843286.2020.1837576","article-title":"Dengue: current state one year before WHO 2010\u20132020 goals","volume":"77","author":"Wellekens","year":"2022","journal-title":"Acta Clin. Belg."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb1375","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1139\/cjm-2020-0572","article-title":"Dengue virus: epidemiology, biology, and disease aetiology","volume":"67","author":"Roy","year":"2021","journal-title":"Can. J. Microbiol."},{"issue":"Supplement_4","key":"10.1016\/j.lfs.2024.123340_bb1380","doi-asserted-by":"crossref","first-page":"S830","DOI":"10.1093\/clinids\/11.Supplement_4.S830","article-title":"Antibody, macrophages, dengue virus infection, shock, and hemorrhage: a pathogenetic cascade","volume":"11","author":"Halstead","year":"1989","journal-title":"Rev. Infect. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1385","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s40259-022-00531-z","article-title":"Dengue vaccines: an update","volume":"36","author":"Torres-Flores","year":"2022","journal-title":"BioDrugs"},{"issue":"7","key":"10.1016\/j.lfs.2024.123340_bb1390","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.3201\/eid2207.151990","article-title":"A literature review of Zika virus","volume":"22","author":"Plourde","year":"2016","journal-title":"Emerg. Infect. Dis."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1395","doi-asserted-by":"crossref","DOI":"10.1016\/0035-9203(52)90043-6","article-title":"Zika virus (II). Pathogenicity and physical properties","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1400","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/0035-9203(52)90042-4","article-title":"Zika virus (I). Isolations and serological specificity","volume":"46","author":"Dick","year":"1952","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.lfs.2024.123340_bb1405","series-title":"Zika Virus Spreads to New Areas\u2014Region of the Americas, May 2015\u2013January 2016","first-page":"1031","author":"Hennessey","year":"2016"},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1410","doi-asserted-by":"crossref","first-page":"851","DOI":"10.3390\/v14050851","article-title":"Excretion of cell-free and cell-associated Zika virus into breast milk of infected dams and identification of antiviral factors","volume":"14","author":"Desgraupes","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.lfs.2024.123340_bb1415","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.584814","article-title":"Epidemic trend and molecular evolution of HV family in the main hantavirus epidemic areas from 2004 to 2016, in PR China","volume":"10","author":"Wang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb1420","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/jmv.21332","article-title":"Antiviral effect of human saliva against hantavirus","volume":"80","author":"Hardestam","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.lfs.2024.123340_bb1425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mrrev.2016.07.002","article-title":"Human papillomavirus molecular biology","volume":"772","author":"Harden","year":"2017","journal-title":"Mutat. Res. Rev. Mutat. Res."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1430","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.antiviral.2007.03.012","article-title":"The anti-papillomavirus activity of human and bovine lactoferricin","volume":"75","author":"Mistry","year":"2007","journal-title":"Antivir. Res."},{"issue":"Suppl2","key":"10.1016\/j.lfs.2024.123340_bb1435","first-page":"12","article-title":"Optimized transferosomal bovine lactoferrin (BLF) as a promising novel non-invasive topical treatment for genital warts caused by human papiluma virus (HPV)","volume":"17","author":"Hadidi","year":"2018","journal-title":"Iran. J. Pharm. Res."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb1440","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jcv.2009.12.006","article-title":"Human polyoma viruses and disease with emphasis on clinical BK and JC","volume":"47","author":"Boothpur","year":"2010","journal-title":"J. Clin. Virol."},{"issue":"7712","key":"10.1016\/j.lfs.2024.123340_bb1445","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(71)91776-4","article-title":"New human papovavirus (BK) isolated from urine after renal transplantation","volume":"297","author":"Gardner","year":"1971","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1450","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"71","author":"Knowles","year":"2003","journal-title":"J. Med. Virol."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb1455","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S1473-3099(03)00770-9","article-title":"Polyomavirus Bk","volume":"3","author":"Hirsch","year":"2003","journal-title":"Lancet Infect. Dis."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb1460","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein\u2013Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2024.123340_bb1465","series-title":"Epstein Barr Virus. Infections of the Central Nervous System","first-page":"175","author":"Hoover","year":"2004"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1470","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.lfs.2024.123340_bb1475","doi-asserted-by":"crossref","first-page":"383","DOI":"10.5581\/1516-8484.20110103","article-title":"Epstein-Barr virus: general factors, virus-related diseases and measurement of viral load after transplant","volume":"33","author":"Gequelin","year":"2011","journal-title":"Rev. Bras. Hematol. Hemoter."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb1480","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jop.12231","article-title":"Association of Epstein-Barr virus infection with oral squamous cell carcinoma in a case\u2013control study","volume":"44","author":"Acharya","year":"2015","journal-title":"J. Oral Pathol. Med."},{"issue":"10","key":"10.1016\/j.lfs.2024.123340_bb1485","first-page":"4201","article-title":"Viral and molecular aspects of oral cancer","volume":"32","author":"Hillbertz","year":"2012","journal-title":"Anticancer Res."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1490","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/0006-291X(89)92292-4","article-title":"Pertussis toxin inhibits differentiation induced by retinoic acid in a human promyelocytic leukemia cell line HL-60","volume":"163","author":"Hemmi","year":"1989","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1495","doi-asserted-by":"crossref","DOI":"10.1002\/iid3.972","article-title":"The immunomodulatory effects of lactoferrin and its derived peptides on NF-\u03baB signaling pathway: a systematic review and meta-analysis","volume":"11","author":"Yami","year":"2023","journal-title":"Immun. Inflamm. Dis."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1500","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.bbagen.2011.06.018","article-title":"Lactoferrin a multiple bioactive protein: an overview","volume":"1820","author":"Garc\u00eda-Montoya","year":"2012","journal-title":"Biochim. Biophys. Acta."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1505","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/ijms18030501","article-title":"Lactoferrin: balancing ups and downs of inflammation due to microbial infections","volume":"18","author":"Drago-Serrano","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2024.123340_bb1510","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fimmu.2017.01438","article-title":"Lactoferrin in a context of inflammation-induced pathology","volume":"8","author":"Kruzel","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2024.123340_bb1515","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1007\/s00018-005-5368-9","article-title":"Lactoferrin: molecular structure, binding properties and dynamics of lactoferrin","volume":"62","author":"Baker","year":"2005","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.lfs.2024.123340_bb1520","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/978-0-387-74087-4_6","article-title":"Lactoferrin structure and functions","volume":"606","author":"Legrand","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1525","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1096\/fj.07-098038","article-title":"Lactoferrin, a major defense protein of innate immunity, is a novel maturation factor for human dendritic cells","volume":"22","author":"Spadaro","year":"2008","journal-title":"FASEB J."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1530","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1139\/o11-056","article-title":"Lactoferrin, a key molecule in immune and inflammatory processes","volume":"90","author":"Legrand","year":"2012","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123340_bb1535","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2021.759507","article-title":"The functional role of Lactoferrin in intestine mucosal immune system and inflammatory bowel disease","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Nutr."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1540","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1093\/advances\/nmac047","article-title":"Effect of lactoferrin supplementation on inflammation, immune function, and prevention of respiratory tract infections in humans: a systematic review and meta-analysis","volume":"13","author":"Berthon","year":"2022","journal-title":"Adv. Nutr."},{"issue":"11","key":"10.1016\/j.lfs.2024.123340_bb1545","first-page":"4174","article-title":"Immunomodulatory agents as potential therapeutic or preventive strategies for COVID-19","volume":"25","author":"Gaziano","year":"2021","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1550","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s10534-022-00436-y","article-title":"Lactoferrin and its digestive peptides induce interferon-\u03b1 production and activate plasmacytoid dendritic cells ex vivo","volume":"36","author":"Kubo","year":"2023","journal-title":"Biometals"},{"key":"10.1016\/j.lfs.2024.123340_bb1555","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ebiom.2016.07.012","article-title":"Lactoferrin suppresses neutrophil extracellular traps release in inflammation","volume":"10","author":"Okubo","year":"2016","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb1560","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1097\/MIB.0000000000000460","article-title":"Neutrophil extracellular traps in ulcerative colitis: a proteome analysis of intestinal biopsies","volume":"21","author":"Bennike","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb1565","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/nu10091228","article-title":"Lactoferrin: a critical player in neonatal host defense","volume":"10","author":"Telang","year":"2018","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1570","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.intimp.2011.11.002","article-title":"Lactoferrin-lipopolysaccharide (LPS) binding as key to antibacterial and antiendotoxic effects","volume":"12","author":"Drago-Serrano","year":"2012","journal-title":"Int. Immunopharmacol."},{"issue":"7","key":"10.1016\/j.lfs.2024.123340_bb1575","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0161-5890(03)00152-4","article-title":"Lactoferrin\u2014a multifunctional protein with antimicrobial properties","volume":"40","author":"Farnaud","year":"2003","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1580","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1046\/j.1523-1755.2000.00050.x","article-title":"Expression of lactoferrin in the kidney: implications for innate immunity and iron metabolism","volume":"57","author":"\u00c5brink","year":"2000","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1585","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0167-4889(98)00013-5","article-title":"Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells","volume":"1402","author":"Damiens","year":"1998","journal-title":"Biochim. Biophys. Acta."},{"issue":"4","key":"10.1016\/j.lfs.2024.123340_bb1590","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jlb.51.4.343","article-title":"Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin","volume":"51","author":"Shau","year":"1992","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1595","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.febslet.2011.12.011","article-title":"Human lactoferrin suppresses TNF-\u03b1-induced intercellular adhesion molecule-1 expression via competition with NF-\u03baB in endothelial cells","volume":"586","author":"Kim","year":"2012","journal-title":"FEBS Lett."},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1600","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/fsn3.388","article-title":"A nutritional supplement containing lactoferrin stimulates the immune system, extends lifespan, and reduces amyloid \u03b2 peptide toxicity in Caenorhabditis elegans","volume":"5","author":"Martorell","year":"2017","journal-title":"Food Sci. Nutr."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb1605","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.nutres.2008.05.007","article-title":"Bovine lactoferrin supplementation supports immune and antioxidant status in healthy human males","volume":"28","author":"Mulder","year":"2008","journal-title":"Nutr. Res."},{"key":"10.1016\/j.lfs.2024.123340_bb1610","doi-asserted-by":"crossref","first-page":"11954","DOI":"10.1039\/D2FO02371G","article-title":"A comprehensive review on lactoferrin: a natural multifunctional glycoprotein","volume":"13","author":"Shini","year":"2022","journal-title":"Food Funct."},{"issue":"9","key":"10.1016\/j.lfs.2024.123340_bb1615","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1248\/bpb.28.1717","article-title":"Liposomalization of lactoferrin enhanced it\u2019s anti-inflammatory effects via oral administration","volume":"28","author":"Ishikado","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.lfs.2024.123340_bb1620","doi-asserted-by":"crossref","first-page":"752","DOI":"10.3390\/molecules21060752","article-title":"Antimicrobial activity of lactoferrin-related peptides and applications in human and veterinary medicine","volume":"21","author":"Bruni","year":"2016","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1625","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ctim.2012.12.006","article-title":"The clinical efficacy of a bovine lactoferrin\/whey protein Ig-rich fraction (lf\/IgF) for the common cold: a double blind randomized study","volume":"21","author":"Vitetta","year":"2013","journal-title":"Complement. Ther. Med."},{"issue":"S1","key":"10.1016\/j.lfs.2024.123340_bb1630","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1017\/S002202990500110X","article-title":"Biological effects of milk proteins and their peptides with emphasis on those related to the gastrointestinal ecosystem","volume":"72","author":"Baldi","year":"2005","journal-title":"J. Dairy Res."},{"issue":"12","key":"10.1016\/j.lfs.2024.123340_bb1635","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1136\/adc.64.12.1685","article-title":"Diet and faecal flora in the newborn: lactoferrin","volume":"64","author":"Balmer","year":"1989","journal-title":"Arch. Dis. Child."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1640","first-page":"220","article-title":"Nutrition in the preterm infant: what\u2019s new?","volume":"19","author":"Cleminson","year":"2016","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"issue":"10170","key":"10.1016\/j.lfs.2024.123340_bb1645","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(18)32221-9","article-title":"Enteral lactoferrin supplementation for very preterm infants: a randomised placebo-controlled trial","volume":"393","author":"Griffiths","year":"2019","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1650","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1139\/o11-070","article-title":"Delta-lactoferrin, an intracellular lactoferrin isoform that acts as a transcription factor1This article is part of a Special Issue entitled Lactoferrin and has undergone the Journal\u2019s usual peer review process","volume":"90","author":"Christophe","year":"2012","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.lfs.2024.123340_bb1655","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejogrb.2017.10.003","article-title":"Lactoferrin or ferrous salts for iron deficiency anemia in pregnancy: a meta-analysis of randomized trials","volume":"219","author":"Hashim","year":"2017","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2024.123340_bb1660","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10534-022-00471-9","article-title":"Review, role of lactoferrin in preventing preterm delivery","volume":"36","author":"Otsuki","year":"2023","journal-title":"Biometals"},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1665","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3390\/biomedicines9080898","article-title":"Lactoferrin for prevention and treatment of anemia and inflammation in pregnant women: a comprehensive review","volume":"9","author":"Artym","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.lfs.2024.123340_bb1670","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jpeds.2019.08.030","article-title":"Improved neurodevelopmental outcomes associated with bovine milk fat globule membrane and lactoferrin in infant formula: a randomized, controlled trial","volume":"215","author":"Li","year":"2019","journal-title":"J. Pediatr."},{"issue":"1","key":"10.1016\/j.lfs.2024.123340_bb1675","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3177\/jnsv.66.24","article-title":"Dose effect of bovine lactoferrin fortification on iron metabolism of anemic infants","volume":"66","author":"Chen","year":"2020","journal-title":"J. Nutr. Sci. Vitaminol."},{"key":"10.1016\/j.lfs.2024.123340_bb1680","doi-asserted-by":"crossref","first-page":"584","DOI":"10.3389\/fimmu.2017.00584","article-title":"Innate immunity and breast milk","volume":"8","author":"Cacho","year":"2017","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.lfs.2024.123340_bb1685","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1001\/jama.2009.1403","article-title":"Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial","volume":"302","author":"Manzoni","year":"2009","journal-title":"JAMA"},{"issue":"03","key":"10.1016\/j.lfs.2024.123340_bb1690","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-0039-1696676","article-title":"Lactoferrin supplementation to prevent late-onset sepsis in preterm infants: a meta-analysis","volume":"38","author":"Razak","year":"2021","journal-title":"Am. J. Perinatol."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1695","article-title":"Enteral lactoferrin for the treatment of sepsis and necrotizing enterocolitis in neonates","volume":"5","author":"Pammi","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"5","key":"10.1016\/j.lfs.2024.123340_bb1700","article-title":"Lactoferrin for the postoperative management of term neonates after gastrointestinal surgery","volume":"5","author":"Trivedi","year":"2023","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2024.123340_bb1705","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2021.111288","article-title":"Dose effect of bovine lactoferrin fortification on diarrhea and respiratory tract infections in weaned infants with anemia: a randomized, controlled trial","volume":"90","author":"Chen","year":"2021","journal-title":"Nutrition"},{"issue":"8","key":"10.1016\/j.lfs.2024.123340_bb1710","article-title":"Does Daily Intake of Bovine Lactoferrin-Containing Products Ameliorate Rotaviral Gastroenteritis?","volume":"96","author":"Egashira","year":"2007","journal-title":"Acta"},{"issue":"2","key":"10.1016\/j.lfs.2024.123340_bb1715","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/MPG.0b013e31802c41b7","article-title":"Efficacy of rice-based oral rehydration solution containing recombinant human lactoferrin and lysozyme in Peruvian children with acute diarrhea","volume":"44","author":"Zavaleta","year":"2007","journal-title":"J. Pediatr. Gastroenterol. Nutr."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524009305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320524009305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:48:27Z","timestamp":1777423707000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320524009305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":343,"alternative-id":["S0024320524009305"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123340","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review of research advances in the study of lactoferrin to treat viral infections","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2024.123340","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123340"}}